Paul Campanelli, EVP, Pres-Par Pharmaceutical at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 47,320 shares at $30.70 ($1.5M) on 2011-03-08, disclosed to the SEC on 2011-03-09.
Seasonal sale ($1.5M) by EVP, Pres-Par Pharmaceutical — this insider has traded PRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.57 | 482 | $15K | 1.0% |
| 2 | $30.58 | 100 | $3K | 0.2% |
| 3 | $30.58 | 975 | $30K | 2.1% |
| 4 | $30.59 | 300 | $9K | 0.6% |
| 5 | $30.60 | 100 | $3K | 0.2% |
| 6 | $30.61 | 400 |
| $12K |
| 0.8% |
| 7 | $30.62 | 930 | $28K | 2.0% |
| 8 | $30.63 | 1,637 | $50K | 3.4% |
| 9 | $30.64 | 1,275 | $39K | 2.7% |
| 10 | $30.65 | 300 | $9K | 0.6% |
| 11 | $30.66 | 200 | $6K | 0.4% |
| 12 | $30.67 | 100 | $3K | 0.2% |
| 13 | $30.68 | 600 | $18K | 1.3% |
| 14 | $30.69 | 700 | $21K | 1.5% |
| 15 | $30.70 | 800 | $25K | 1.7% |
| 16 | $30.71 | 600 | $18K | 1.3% |
| 17 | $30.72 | 300 | $9K | 0.6% |
| 18 | $30.73 | 1,100 | $34K | 2.3% |
| 19 | $30.74 | 2,500 | $77K | 5.3% |
| 20 | $30.75 | 24,732 | $761K | 52.3% |
| 21 | $30.75 | 200 | $6K | 0.4% |
| 22 | $30.76 | 5,097 | $157K | 10.8% |
| 23 | $30.77 | 2,335 | $72K | 4.9% |
| 24 | $30.78 | 434 | $13K | 0.9% |
| 25 | $30.79 | 723 | $22K | 1.5% |
| 26 | $30.80 | 300 | $9K | 0.6% |
| 27 | $30.81 | 100 | $3K | 0.2% |
| Total | $30.73 avg | 47,320 | $1.5M | 100% |
| Filing → |
| ENDP | BUY | 2016-05-11 | $202K | — | Filing → |
| ENDP | BUY | 2015-11-12 | $117K | — | Filing → |
| PRX | SELL | 2011-03-09 | $466K | — | Filing → |